Pharmacogenomic testing for antidepressants could help reduce the time and cost it takes to find the most effective medication for a patient, according to a new study. Scientists developed a ...

As more patients speak up about the frustrations of trial-and-error mental health medication treatment, important questions are emerging about what personalized care really looks like and how genetic ...

For many people living with ADHD, finding the right medication can mean years of trial and error: multiple attempts, ...

An economic analysis presented at the 2017 Neuroscience Educational Institute (NEI) Congress in Colorado Springs, Colorado, showed that pharmacogenomic testing in patients with specific psychiatric ...

LAS VEGAS -- Families who received the results of pharmacogenomic testing for their children at one center understood the results they received but didn't often share the test results with other ...

Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC often involves androgen deprivation therapy ...

Pharmacogenomic testing, a mature and growing aspect of personalized medicine, has demonstrated significant ability to enhance health outcomes and reduce healthcare costs. Since the 1970s, ...

Pharmacogenetic testing, which is used to classify how patients with major depressive disorder (MDD) metabolize medications, reduces adverse drug-gene interactions, new research shows. In a randomized ...

Genetics are increasingly playing a role in various aspects of healthcare, and mood and psychiatric disorders are no exception. AJMC ®: How important are genetics in mood and psychotic disorders, and ...

SALT LAKE CITY, June 11, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, acknowledges the release of a final local coverage ...

Two major Australian health insurers, Bupa and Medibank, have started offering genetic testing meant to tell you your likely reaction to certain medications. These include antidepressants, pain ...

ROCKVILLE, Md. - Sept. 4, 2019 - The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published a new position statement for ...